The capture of mixed-disulfide complexes
between each alanine substitution mutant of Ero1p-myc and CGHS–CGHS
Pdi1p or CQHA Mpdp2. Cells overproducing a single alanine-substitution
mutant of Ero1p-myc in addition to CGHS–CGHS Pdi1p were labeled with
[35S]methionine and cysteine and then suspended in 10%
TCA to block further thiol–disulfide exchange in vivo. Ero1p-Pdi1p
mixed disulfides were isolated by modifying free thiols with NEM
prior to immunoprecipitation with anti-myc antibody under nonreducing
but denaturing conditions. The primary immunoprecipitates were reduced
with 100 mM DTT prior to reimmunoprecipitation with either anti-myc
(1× loading) or anti-Pdi1p (7.5× loading) antibody. Samples were
resolved by SDS-PAGE and analyzed with a 445si phosphorimager.
The efficiency of mixed-disulfide capture is expressed as the ratio of
the band intensity of reimmunoprecipitated Pdi1p to that of
reimmunoprecipitated Ero1p-myc (per OD600 U of extract),
normalized to the value obtained with wild-type Ero1p-myc. (A) Strains
derived from CKY598 (ero1-1 GAL2) were grown in SMM
Raf/Gal and labeled at restrictive temperature (38°C). (B) Otherwise
isogenic strains derived from CKY263 (GAL2) were labeled
at 30°C. The strains shown were transformed with pAF132
[PGAL1-pdi1-1966] in addition to the
following: WT, pAF89 [2μ ERO1-myc];
90, pAF124 [2μ ero1-A90-myc];
100, pAF125 [2μ ero1-A100-myc]; 105,
pAF126 [2μ ero1-A105-myc]; 208,
pAF127 [2μ ero1-A208-myc]; 349,
pAF128 [2μ ero1-A349-myc]; 352,
pAF129 [2μ ero1-A352-myc]; or 355,
pAF130 [2μ ero1-A355-myc]. (C) Mixed
disulfides between CQHA Mpd2p and each alanine substitution mutant of
Ero1p-myc were isolated as described above from wild-type cells
(CKY263) transformed with pAF123
[PGAL1-mpd2p-CQHA] instead of
pAF132, and the complexes resolved directly by nonreducing SDS-PAGE.
The efficiency of mixed-disulfide capture is expressed as the ratio of
the band intensity of the Mpd2p-Ero1p-myc complexes to free Ero1p-myc,
normalized to the value obtained with wild-type Ero1p-myc.